Jefferies Group LLC Aerie Pharmaceuticals Inc Call Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Sep 21, 2023	BUY	$7.02 - $13.33 $351,000 - $666,500	50,000 New	50,000 $351,000
Q4 2021 Feb 14, 2022	BUY	$7.02 - $13.33 $351,000 - $666,500	50,000 New	50,000 $351,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $1.34 Million - $2.89 Million	-113,300 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$17.72 - $25.1 $2.01 Million - $2.84 Million	113,300 New	113,300 $2.74 Million
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $819,790 - $1.08 Million	-14,600 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $698,610 - $1.03 Million	14,600 New	14,600 $986,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.